Comparison of genotypic and virtual phenotypic drug resistance interpretations with laboratory-based phenotypes among CRF01_AE and subtype B HIV-infected individuals

• Main Authors: Awachana Jiamsakul, Romanee Chaiwarith, Nicolas Durier, Sunee Sirivichayakul, Sasisopin Kiertiburanakul, Peter Van Den Eede, Rossana Ditangco, Adeeba Kamarulzaman, Patrick Ck Li, Winai Ratanasuwan, Thira Sirisanthana, P. C.K. Li, M. P. Lee, N. Kumarasamy, S. Saghayam, S. Pujari, K. Joshi, T. P. Merati, F. Yuliana, C. K.C. Lee, B. L.H. Sim, L. Y. Ong, M. Mustafa, N. Nordin, R. O. Bantique, Y. M.A. Chen, Y. T. Lin, P. Phanuphak, S. Sirivichayakul, S. Sungkanuparph, L. Chumla, N. Sanmeema, J. Praparattanapan, P. Kantipong, P. Kambua, R. Sriondee, R. Kantor, A. H. Sohn, T. Singtoroj, D. A. Cooper, M. G. Law, D. C. Boettiger
• 其他作者: University of New South Wales (UNSW) Australia
• 格式: Article
• 出版: 2018
• 主題: Immunology and Microbiology
• 在線閱讀: https://repository.li.mahidol.ac.th/handle/123456789/40884

© 2016 Wiley Periodicals, Inc. HIV drug resistance assessments and interpretations can be obtained from genotyping (GT), virtual phenotyping (VP) and laboratory-based phenotyping (PT). We compared resistance calls obtained from GT and VP with those from PT (GT-PT and VP-PT) among CRF01_AE and subtyp...